Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction

Overview of attention for article published in Molecular Medicine, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 1,264 followers.

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction https://t.co/mE6aUOoYnn

11 May 2022

Reply Repost Favourite

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction. https://t.co/PJFG98s2wO https://t.co/Xuitg1TDxO

07 May 2022

Reply Repost Favourite

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction https://t.co/2wycFfIIn9 https://t.co/IuosuE392K

06 May 2022

Reply Repost Favourite

New article: Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction https://t.co/b4TCI8vUvz #melanoma #oncology https://t.co/UXIuTu3B4v

05 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.